Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cerny

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infectionR Nayersina, P Fowler, S Guilhot, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2016
Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman PrimatesSteven M Weldon, Matthew A Cerny, Kristina Gueneva-Boucheva, et al.
Molecular Pharmaceutics|May 3, 2023
Characterization of Bile Acid Sulfate Conjugates as Substrates of Human Organic Anion Transporting PolypeptidesChristine C Orozco, Mikko Neuvonen, Yi-An Bi, et al.
Behavioural Brain Research|December 3, 2014
Extinction retention and fear renewal in a lifetime obsessive-compulsive disorder sampleN C R McLaughlin, D Strong, A Abrantes, et al.
BMC Research Notes|November 10, 2020
Direct application of an ECG-based sleep staging algorithm on reflective photoplethysmography data decreases performanceM M van Gilst, B M Wulterkens, P Fonseca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1989
Functional and phenotypic alterations in T cell subsets during the course of MAIDS, a murine retrovirus-induced immunodeficiency syndromeH C Morse, R A Yetter, C S Via, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 7, 2024
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in HumansJonathan N Bauman, Angela C Doran, Gabrielle M Gualtieri, et al.
Clinical Pharmacology and Therapeutics|September 22, 2020
Identification of Glycochenodeoxycholate 3-O-Glucuronide and Glycodeoxycholate 3-O-Glucuronide as Highly Sensitive and Specific OATP1B1 BiomarkersMikko Neuvonen, Päivi Hirvensalo, Aleksi Tornio, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 29, 2025
Pharmacodynamic effects of highly selective aldosterone synthase inhibitor vicadrostat in cynomolgus monkeys: Contrasting effects of once versus twice daily dosingSteven M Weldon, Derek A Cogan, Matthew A Cerny, et al.
Gut|July 16, 2008
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infectionB Helbling, K Overbeck, J-J Gonvers, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infectionR Nayersina, P Fowler, S Guilhot, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2016
Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman PrimatesSteven M Weldon, Matthew A Cerny, Kristina Gueneva-Boucheva, et al.
Molecular Pharmaceutics|May 3, 2023
Characterization of Bile Acid Sulfate Conjugates as Substrates of Human Organic Anion Transporting PolypeptidesChristine C Orozco, Mikko Neuvonen, Yi-An Bi, et al.
Behavioural Brain Research|December 3, 2014
Extinction retention and fear renewal in a lifetime obsessive-compulsive disorder sampleN C R McLaughlin, D Strong, A Abrantes, et al.
BMC Research Notes|November 10, 2020
Direct application of an ECG-based sleep staging algorithm on reflective photoplethysmography data decreases performanceM M van Gilst, B M Wulterkens, P Fonseca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1989
Functional and phenotypic alterations in T cell subsets during the course of MAIDS, a murine retrovirus-induced immunodeficiency syndromeH C Morse, R A Yetter, C S Via, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 7, 2024
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in HumansJonathan N Bauman, Angela C Doran, Gabrielle M Gualtieri, et al.
Clinical Pharmacology and Therapeutics|September 22, 2020
Identification of Glycochenodeoxycholate 3-O-Glucuronide and Glycodeoxycholate 3-O-Glucuronide as Highly Sensitive and Specific OATP1B1 BiomarkersMikko Neuvonen, Päivi Hirvensalo, Aleksi Tornio, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 29, 2025
Pharmacodynamic effects of highly selective aldosterone synthase inhibitor vicadrostat in cynomolgus monkeys: Contrasting effects of once versus twice daily dosingSteven M Weldon, Derek A Cogan, Matthew A Cerny, et al.
Gut|July 16, 2008
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infectionB Helbling, K Overbeck, J-J Gonvers, et al.
Pageof 15